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Abstract
Background: The progression of normal cells through the cell cycle is meticulously regulated by
checkpoints guaranteeing the exact replication of the genome during S-phase and its equal division
at mitosis. A prerequisite for this achievement is synchronized DNA-replication and centrosome
duplication. In this context the expression of cyclins A and E has been shown to play a principal role.
Results: Our results demonstrated a correlation between centrosome amplification, cell cycle
fidelity and the level of mRNA and protein expression of cyclins A and E during the part of the cell
cycle defined as G1-phase by means of DNA content based histogram analysis. It is shown that the
normal diploid breast cell line HTB-125, the genomically relatively stable aneuploid breast cancer
cell line MCF-7, and the genomically unstable aneuploid breast cancer cell line MDA-231 differ
remarkably concerning both mRNA and protein expression of the two cyclins during G1-phase. In
MDA-231 cells the expression of e.g. cyclin A mRNA was found to be ten times higher than in MCF-
7 cells and about 500 times higher than in HTB-125 cells. Topoisomerase II α showed high mRNA
expression in MDA compared to MCF-7 cells, but the difference in protein expression was small.
Furthermore, we measured centrosome aberrations in 8.4% of the MDA-231 cells, and in only 1.3%
of the more stable aneuploid cell line MCF-7. MDA cells showed 27% more incorporation of BrdU
than reflected by S-phase determination with flow cytometric DNA content analysis, whereas these
values were found to be of the same size in both HTB-125 and MCF-7 cells.
Conclusions: Our data indicate that the breast cancer cell lines MCF-7 and MDA-231, although
both DNA-aneuploid, differ significantly regarding the degree of cell cycle disturbance and
centrosome aberrations, which partly could explain the different genomic stability of the two cell
lines. The results also question the reliability of cytometric DNA content based S-phase
determination in genomically unstable tumor cell populations.
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Background
The centrosome is the major microtubule-organising cen-
tre in mammalian cells and is a principal part of the
cytoskeleton. It consists of two barrel-shaped centrioles
surrounded by pericentriolar material [1] and reproduces
during interphase of the cell cycle. During mitosis the cen-
trosome functions as spindle pole, assembling spindle
microtubules to guarantee correct chromosome separa-
tion [2,3]. The centrosome duplication cycle proceeds in
exact coordination with other cell cycle events, including
DNA replication [4]. Recent studies report that centro-
some duplication requires phosphorylation of pRb, E2F
transcription factors and cdk2 activity [3]. In late G1, prior
to the initiation of DNA synthesis, cdk2 associates with
cyclin E, which is a vital prerequisite for entrance into S-
phase and also centrosome duplication [5,6]. Evidence
has been obtained that overexpression of cyclin E acceler-
ates the G1/S passage [7,8]. At this point cyclin A can be
detected, which also binds to and activates cdk2. Cyclin A
increases during S and G2-phase and is degenerated in
mitosis [9–11]. Deviating expression of cyclin A and E
results in abolished coordination between initiation of
centrosome duplication and DNA replication [12]. It has
been previously demonstrated that cyclin E protein and
mRNA overexpression is common in human breast can-
cers [13,14].
The highly conserved topoisomerase II α [15,16] is a
nuclear enzyme that controls the topological state of DNA
and is indispensable for DNA replication, recombination
and possibly transcription [17,18]. It also directs conden-
sation and segregation of mitotic chromosomes. Topoi-
somerase II α expression is low in G1-phase, increases in
S-phase and reaches its maximum in G2/M-phase [16,19].
Failure in coordination of the centrosome duplication
and DNA replication cycles inevitably leads to centrosome
aberrations, followed by impaired distribution of chro-
mosomes at cell division, and thus to genomic instability
[20,21]. Numerical and qualitative changes of centro-
somes are common in human cancers, and are suggested
to be one of the principal causes of genomic instability
[22,23].
Image cytometric measurements in serum starved diploid
HTB-125 and aneuploid MCF-7 and MDA-231 breast cell
lines demonstrated a clear difference in the percentage of
cells with nonmodal DNA content values (Fig. 1) as man-
ifestation of genomic instability. Remarkably this differ-
ence was also evident comparing the two aneuploid cell
lines in demonstrating MCF-7 cells as being genomically
more stable than the MDA-231 cell line.
The aim of our investigation is focused on the expression
of cyclins A, E and topoisomerase II α in relation to cen-
trosomal abnormalities and genomic instability, and the
significance of these cell cycle abnormalities on the relia-
bility of cytometric S-phase determination.
Results
Image cytometry
Figure 1 illustrates the image DNA histograms of HTB-
125, MCF-7 and MDA-231 cultured for 72 hours in
medium containing 0.1% FBS. The diploid HTB-125 and
the aneuploid MCF-7 showed distinct stemlines without
any S-phase fraction and other nonmodal DNA content
values. The aneuploid MDA-231 cell line however was
characterized by both an unchanged high S-phase and
DNA content values clearly deviating from the modal
value of the stemline (notice in figure 1 values to the left
of the stemline and values exceeding 6c).
mRNA levels of cyclins A, E and topoisomerase II α
Real time quantitative PCR is a very precise method to
determine mRNA and DNA amounts. We used this tech-
nique to measure the relative mRNA expression levels of
cyclins A, E and topoisomerase II α in MDA-231, MCF-7
and HTB-125 cells, which were assorted by centrifugal elu-
triation to be in G1-phase. The proportion of the G1 cells
according to the cellular DNA measurement was 99%,
97%, and 93% for the HTB-125, MCF-7 and MDA-231
cells respectively. The intra-assay CVs (Coefficient of Vari-
ation) of the real time measurements were cyclin A 1.8%,
cyclin E 1.9%, topoisomerase II α 2.3%. The inter-assay
CVs were cyclin A 4.1%, cyclin E 4.3% and topoisomerase
II α 4.4%.
Figure 2 demonstrates a high cyclin A mRNA level in
MDA-231 cells. The amount of transcripts was 10 times
higher than in MCF-7 cells and about 500 times higher
than in the HTB-125 cell line. The mRNA levels of cyclin
E and topoisomerase II α were also high in the MDA-231
cell line, as compared with the corresponding transcript
levels in MCF-7 and HTB-125 cells. Thus, cyclin A and
topoisomerase II α, decisive for DNA synthesis and cyclin
E, regulating the onset of DNA replication, showed a
strong upregulation of their mRNA levels in G1-phase
cells of the aneuploid breast cancer cell line MDA-231. In
MCF-7 cells this upregulation was rather moderate. That
could give a hint at MCF-7 cells still being more under cell
cycle control than MDA-231 cells.
An important by-product of our investigation was the
confirmation of 18S rRNA being an endogenous control
for real time PCR with stable expression levels throughout
the cell cycle. There was no detectable difference in 18S
rRNA amount between MDA-231 cells in G1-phase and
asynchronous MDA-231 cells.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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Image cytometry Figure 1
Image cytometry Nuclear DNA content of the cell lines HTB-125, MCF-7 and MDA-231, exposed to serum starvation, and 
measured by image cytometry of Feulgen stained cells (2c denotes diploid DNA content). We measured 204 cells of the MDA-
231 cell line, and 150 cells in MCF-7 and HTB-125 each. G1 indicates the percentage of cells in G1-phase of the cell cycle. S and 
G2 indicate the percentage of cells in S and G2-phase, respectively. G2 Exc is the percentage of cells with DNA content values 
exceeding twice the modal value plus 1c.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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Cyclins A, E and topoisomerase II α protein expression
HTB-125, MCF-7 and MDA-231 cells were stained indi-
rectly with anticyclin A, E and anti topoisomerase II α
monoclonal antibodies, and propidium iodide. We ana-
lysed and compared specific staining only in the region
corresponding to G1-phase.
Figure 2 illustrates 58% (SE (standard error of the mean)
= 2.1%) of positive cells for cyclin A in MDA-231, 16
times more than we measured in MCF-7 cells (SE = 1.6%).
Cyclin E protein expression was about two times higher in
MDA-231 (SE = 3.9%) than in MCF-7 cells (SE = 4.1%),
which was still in quite good accordance with the corre-
sponding mRNA measurements. In the case of topoi-
somerase II α however, the upregulation between MCF-7
and MDA-231 cells on the mRNA level (16 times) differed
considerably from those of the protein level (1.2 times). It
should be noticed that mRNA and protein expression are
not always directly related to each other.
Determination of S-phase fraction by single parameter 
DNA cytometry as compared with two-parameter DNA-
BrdU cytometry
The upper part of figure 3 shows DNA histograms (a, c
and e) of the three cell lines that are compared with results
from the same cell material double stained for DNA-BrdU
(b, d, f) in the lower part of the figure. In case of the dip-
loid cell line the S-phase fraction (SE = 1.2%) calculated
from the DNA histogram is in good agreement with the
fraction of BrdU positive cells (SE = 1.5%). Also in the
Real time qPCR and immunoassays Figure 2
Real time qPCR and immunoassays Relative amount of cyclin A, E and topoisomerase II α mRNA determined by running 
real time quantitative PCR on reverse transcribed total RNA, extracted from HTB-125, MCF-7 and MDA-231 cells in G1-
phase, which were assorted by centrifugal elutriation. The algorithm, chosen for calculating the relative amount of target 
mRNA gives values without any units of measurement. The detection range of the instrument is in our case five orders of mag-
nitude. For the protein determination we calculated the percentage of positively stained G1-phase cells that were assorted by 
flow cytometry.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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aneuploid MCF-7 cell line there is only a minor difference
between the S-phase fractions determined by both
methods (SE = 3.1%, 1.8% respectively). In contrast, the
genomically unstable aneuploid cell line MDA-231
showed a substantial difference between the fraction of
BrdU incorporating cells (SE = 1.5%) and the calculated S-
phase population (SE = 1.9%). Thus, according to BrdU
incorporation there were 27% more cells synthesizing
DNA (referred to BrdU incorporation as total amount of
DNA synthesis) than detected, using DNA histogram
based S-phase fraction determination.
Figure 3f shows DNA synthesizing cells in a range of more
than two orders of magnitude, suggesting a genomically
unstable cell population. In addition DNA synthesizing
cells, which were equally distributed between the early,
intermediate and late part of S-phase in the case of the
more stable cell line MCF-7, displayed a clear shift
towards the early part of the S-phase in MDA-231 cells
(picture not shown).
Centrosome staining and analysis
Frequencies of spontaneous centrosome aberrations in
the diploid cell line HTB-125 and in the two human
breast cancer cell lines MCF-7 and MDA-231 were ana-
lysed as described in Materials and Methods (Fig. 4). In
HTB-125, only 0.3% (5 of 1601 cells examined) of the
cells showed aberrant centrosomes, three of which had
three centrosomes per cell and two were irregular in
shape. In contrast, in cancer cells, significantly higher per-
centages of aberrant centrosomes were detected. MCF-7
and MDA-231 showed 1.3% (20 of 1501), and 8.4% (138
Flow cytometry and BrdU incorporation Figure 3
Flow cytometry and BrdU incorporation DNA histograms of HTB-125 (a), MCF-7 (c), MDA-231 (e) cell lines and two 
parameter histograms (BrdU incorporation vs. DNA content) of HTB-125 (b), MCF-7 (d) and MDA-231 (f) cell lines. As one 
can see the S-phases in HTB-125 and MCF-7 are very similar with both methods, but in the unstable aneuploid cell line MDA-
231, there is a very substantial difference between the measurements with the two methods.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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of 1643) cells with hyperamplified centrosomes respec-
tively. In the MDA-231 cell line up to 9 centrosomes per
cell were observed. These abnormally amplified centro-
somes were irregular in shape, or had a bigger size com-
pared with normal ones.
Discussion
In this study we measured with real time quantitative PCR
the mRNA amount of cyclins A, E and topoisomerase II α
in centrifugal elutriated G1-phase cells in the normal
breast tissue derived diploid cell line HTB-125, the
genomically relatively stable aneuploid breast cancer cell
line MCF-7 and the genomically unstable aneuploid
breast cancer cell line MDA-MB-231. The respective pro-
tein amount was determined by indirect immunofluores-
cence. Furthermore, we stained centrosomes in these three
cell lines for hyperamplifications, and we did a compari-
son between the assessment of S-phase according to FCM
and BrdU incorporation.
The three cell lines were chosen as a model for gradually
reduced genomic stability as judged from DNA content
analysis (Fig. 1). In particular the model should demon-
strate different stages of stability among the aneuploid cell
Centosome measurements Figure 4
Centosome measurements Percentage of cells that show more than two centrosomes per cell in the cell lines HTB-125, 
MCF-7 and MDA-231, examined with a Zeiss Axioskop fluorescence microscope.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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lines, manifested by aberrant expression of proliferation
markers. Whereas the MCF-7 cells showed only moderate
disturbance in regulation, compared to HTB-125 cells, the
MDA-231 cell line revealed strongly upregulated cyclin A,
E and topoisomerase II α mRNA and cyclin A, E protein
levels. Topoisomerase II α showed high mRNA expression
in MDA compared to MCF-7 cells, but the difference in
protein expression was small. Taking into account that
cyclin E and A are crucial for G1/S transition, their upreg-
ulation in MDA-231 cells might imply severe disturbance
of regulating this checkpoint. An additional support of
this assumption is the upregulated topoisomerase II α
mRNA level, during the G1-phase of the cell cycle, as
determined by cytometric DNA content measurements.
There are other reports about cyclin A upregulation on the
protein level in breast cancer cell lines and in aneuploid
breast carcinomas [13,24]. Furthermore, there are data
reporting aberrant cyclin E mRNA and protein expression
in breast cancer [14,25].
The data obtained in the present study, indicate the exist-
ence of two different types of aneuploid species repre-
sented by the breast cancer cell line MCF-7, which is
genomically relatively stable, as reflected in DNA content
measurements, and the other breast cancer cell line MDA-
231 that is genomically unstable. One reason for aneu-
ploidy can be unequal distribution of chromosomes
among the daughter cells based on abnormally amplified
centrosomes. P53 seems to be involved in regulation of
centrosome duplication [26,27], which might be one
cause for mutant p53 MDA-231 cells [28] showing, in our
investigation, centrosome hyperamplifications in 8.4% of
the cells. In contrast, MCF-7 cells with wild type p53
showed only in 1.3% of their cells centrosomal aberra-
tions. Another reason for cells to become aneuploid is to
undergo endoreduplication. Treating cells with a compro-
mised G1/S checkpoint or cells that are Rb or p21 negative
with microtubule inhibitors, will make them replicate the
genome without going through mitosis and thus achiev-
ing the status of polyploidy. These cells prove to be unsta-
ble, losing chromosomes randomly to become aneuploid
[29,30]. Furthermore, cyclin A and E seem to be involved
in the process of centrosome duplication [3,5,31,32]. If
cyclin A and E are overexpressed during G1, centrosome
duplication and DNA replication cycles might occur
asynchronously.
Our results show that upregulation of cyclins A, E and
topoisomerase II α as well as centrosome hyperamplifica-
tion might be signs of disturbed G1/S checkpoint regula-
tion preferentially in the unstable aneuploid cell line
MDA-231. In addition, our data indicate the existence of
different graduations of erroneous checkpoint regulation.
MCF-7 cells, although aneuploid, seem to exhibit minor
checkpoint control aberrations in showing also only few
centrosome hyperamplifications.
A further aspect of this work is the comparison between
the assessment of S-phase according to the FCM method
and to the number of BrdU incorporating cells. The basis
of the BrdU method is that cells are pulse-labeled with the
thymidine analogue BrdU, resulting in labeling of DNA
synthesizing cells. Incorporated BrdU is detected by the
use of primary BrdU antibodies, secondary fluorescein
isothiocyanate (FITC)-conjugated antibodies and is then
quantified by FCM analysis. We found that the two sepa-
rate measurements did not give any significant difference
in the normal breast tissue derived cell line and in MCF-7
cells. However, in MDA cells there was 27% more incor-
poration of BrdU than reflected by S-phase determination
with the FCM method. According to the results presented
here, this might at least in part be due to a substantial
number of cells synthesizing DNA, but being located in
the G1 compartment of the DNA content histogram.
Obviously, the broadened trapezoidal model used for fit-
ting of the S-phase underestimates this fraction of BrdU
positive cells in G1. In a recent study, we got positive cor-
relation between 9 years survival and S-phase fraction in
diploid breast tumors, but not in aneuploid ones (to be
published). A possible explanation for this discrepancy
may be that S-phase measurement by FCM does not prove
to be precise and reliable in genomically unstable cells.
The clinical implications are critical since estimation of S-
phase fraction as a measure of tumor growth activity is fre-
quently decisive for choice of therapy.
Conclusions
Taken together our results indicate that the aneuploid
breast cancer cell lines MCF-7 and MDA-MB-231,
although both aneuploid, differ significantly regarding
the fraction of cells expressing cyclins A and E and topoi-
somerase II α (on the mRNA level) during the part of the
cell cycle defined as G1-phase by means of DNA content
based histogram analysis. The degree of this disturbance
seems to be correlated with centrosome hyperamplifica-
tion and may cover aspects of genomic instability. The
results also question the reliability of cytometric DNA
content based S-phase determination in genomically
unstable tumor cell populations.
Methods
Cell lines and culture conditions
The DNA-diploid Hs 578Bst cell line (ATCC-HTB-125)
was derived from normal human breast tissue peripheral
to an infiltrating ductal carcinoma. The cells were grown
in modified Dulbecco's medium with 30 ng/ml EGF
(90%), 50 µg/ml penicillin, 50 µg/ml streptomycin, sup-
plemented with 10% FBS.BMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
Page 8 of 11
(page number not for citation purposes)
The DNA-hypotetraploid MCF-7 cell line (ATCC-HTB-22)
originally came from a human breast adenocarcinoma.
The cells were grown in minimum essential medium
(Gibco BRL) with 2 mM L-glutamine, 0.1 mM non-essen-
tial amino acids, 1.0 mM sodium pyruvate, 50 µg/ml
streptomycin and 10% FBS.
The DNA-hypotriploid MDA-MB-231 cell line (ATCC-
HTB-26) was derived from a human breast adenocarci-
noma. These cells were grown in Dulbecco's MOD eagle
medium (Gibco BRL) with 2 mM L-glutamine, 1.0 mM
sodium pyruvate, 50 µg/ml penicillin, 50 µg/ml strepto-
mycin, and 10% FBS.
The cells were incubated at 37°C in a humid atmosphere
of 5% CO2 in 325 cm2 flasks and were subcultured when
having reached confluence, using 0.25% trypsin-0.03%
EDTA solution (Gibco BRL). For experimental purposes,
cells were seeded at a concentration 10–20,000 cells/cm2
and harvested before having reached confluence. The
medium was removed and the cells were then washed
once in 0.25% trypsin (Gibco). After removing trypsin the
cells were kept at room temperature for 10 minutes. Then
they were shaken vigorously, 10 ml of PBS was added and
the mixture was shaken again. The cell suspension was
transferred to a 15 ml tube. After 5 minutes of centrifuga-
tion at 3,000 RPM, the supernatant was removed and the
cells kept at 4°C until further treatment. Serum starvation
was performed by culturing the cells in medium contain-
ing 0.1% FBS during 72 hours.
Centrifugal elutriation
Separation of cells on the basis of different cell size was
made in a Beckman JE-G centrifugal elutriator rotor. Expo-
nentially growing cells were harvested by trypsination,
washed, and resuspended in respective medium. Approx-
imately 2 × 108 cells were elutriated in each run at 4°C.
The rotor speed was 2,780 rpm, and the initial flow rate
was 12 ml/min. Five fractions were obtained by stepwise
increase of the flow rate up to 45 ml/min. The first fraction
containing partly non-viable cells was discarded. The cells
of the second fraction containing entirely G1 cells were
collected by centrifugation and resuspended in PBS. Since
about 4–6 × 106 cells were needed for the mRNA measure-
ment, fractions from several elutriation runs were stored
in PBS at -20°C. Aliquots were fixed in buffered formalin
for flow-cytometric analysis of the cellular DNA content
as described earlier [33].
Determination of mRNA
G1 cells assorted by centrifugal elutriation were used for
RNA extraction, cDNA synthesis and real time quantita-
tive PCR with an amplicon for cyclins A, E and topoi-
somerase II α.
RNA extraction and DNase treatment
Total RNA was extracted using the Trizol reagent, followed
by treatment with DNAse I (both reagents from Life Tech-
nologies, Paisley, UK). After 15 minutes of incubation at
room temperature, the enzyme was inactivated with 25
mM EDTA, followed by heating for 10 minutes at 70°C to
denature DNase.
cDNA synthesis
We reverse transcribed 2 µg of total RNA in a final reaction
volume of 20 µl, containing 1xFirst Strand Buffer (50 mM
Tris-HCl, 75 mM KCl, 3 mM MgCl2), 100 ng random hex-
amers, 0.1 M DTT, 10 mM dNTP mix, Applied Biosystems
(ABI), 200 units Superscript II RNase H- Reverse Tran-
scriptase and DEPC treated water (all other reagents from
Life Technologies). First, the mixture of total RNA, ran-
dom hexamers and DEPC treated water was kept at 70°C
for 10 minutes and afterwards put on ice. Then the mix
containing buffer, DTT and dNTPs was added, followed
by incubation at 25°C for 10 minutes. After two minutes
at 42°C, the Superscript II was spiked in for the remaining
50 minutes of reverse transcription. We stopped the reac-
tion by heating to 70°C for 15 minutes.
Real time quantitative PCR
With real time PCR the measurement is taking place at a
quite early stage during the polymerase chain reaction. At
the exponential phase of the amplification process, all rea-
gents are still abundant and there is no danger of limiting
conditions, which might interfere with a precise quantita-
tion. This is an advantage over endpoint analysis, where
small variations in starting reaction conditions may esca-
late and lead to totally different final product yield for the
same starting copy number of template [34]. Concerning
real time quantitation the crucial value is the threshold
cycle (CT), which is the fractional cycle number during
PCR at which the amount of amplified target in each sam-
ple reaches a fixed threshold above the background noise
[35,36]. The product accumulation is directly propor-
tional to the increase in fluorescent emission that occurs
if the Taq polymerase is performing a 5'-3' nucleolytic
digestion of the dual-labeled fluorogenic probe, which
has to be hybridized to the template. On the other hand,
the CT-value is inversely proportional to the logarithm of
the initial template copy number [37–39]. As long as the
5'-reporter dye (distinct fluoresceins: FAM, VIC, TET) is in
a certain spatial proximity to the 3'-quencher dye
(TAMRA, 6-carboxy-tetramethylrhodamine), no fluores-
cence is detectable [36].
Relative quantitation of cyclin A, E and topoisomerase II α 
mRNA levels
Cyclin A, E and topoisomerase II α mRNA levels were
determined by performing real time PCR. We did a rela-
tive quantitation according to the comparative CTBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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method, 18S rRNA served as the endogenous external
control and our inter-run standard was cDNA prepared
from asynchronous MDA-MB-231 cells. All PCR-reactions
were performed on a 7700 Sequence Detector (ABI). We
ran each amplicon (cyclins A, E, topoisomerase II α and
18S rRNA) in triplicates for all cell lines. From the mean
CT-values of the respective triplicates the mean CT-value of
the 18S rRNA amplicon was subtracted. The purpose of
the endogenous control is to correct for differences in
pipetting the cDNA from the cell lines and to compensate
for putative reverse transcription and PCR inhibition. This
subtraction gave us ∆CT-values. The CT-value of the inter-
run standard was subtracted from all the other ∆CT-values,
and that resulted in ∆∆CT-values. The last step in getting
the relative amount of target mRNA is to calculate 2-∆∆CT
[40].
Primers, probes and the PCR reaction
Primers and probes for the targets cyclin A, E and topoi-
somerase II α were found with the aid of Primer Express
1.0 (ABI, Foster City, CA), a computer program special-
ized in designing short amplicons for real time PCR. To
exclude an amplification from genomic DNA, we placed
one primer of each amplicon across an exon/exon
junction in getting not more than six bases of the 3'-end
on one exon and the remaining nucleotides of this primer
on the adjoining one. The probes we purchased from ABI,
Warrington, Cheshire, UK; primers were ordered from Life
Technologies. The complete 18S rRNA amplicon was
already designed by ABI.
The reaction volume for the PCR was 25 µl. Each master
mix comprised 1xTaqMan buffer A, 6 mM MgCl2, 200 µM
dATP, dCTP, dGTP, dTTP and 0.625 units of AmpliTaq
Gold DNA polymerase (all reagents from ABI). We used
the probe for cyclins A, E and topoisomerase II α at a con-
centration of 100 nM and the probe for 18S rRNA at a con-
centration of 75 nM. The primers for cyclins A, E and
topoisomerase II α had the concentration of 200 nM, in
the case of the 18S rRNA the concentration of the forward
primer was 50 nM, those of the reverse was 40 nM. Per 25
µl reaction volume 25 ng reverse transcribed total RNA
was added. The thermal cycling conditions were as fol-
lows: 10 minutes at 95°C (activation of the Taq polymer-
ase), and 40 cycles at 95°C for 15 seconds and 62°C for 1
minute. All target genes and the endogenous control were
run in triplicates for all cell lines. Additionally we ran
non-template controls in triplicates for all targets and the
endogenous control.
Image cytometry
Image cytometry was performed on Feulgen stained cells.
The staining and standardization were based on methods
previously described [41].
A cell line was defined as genomically relatively stable
provided that it showed a) confluence and/or serum star-
vation induced growth arrest in G0/G1, b) low percentage
of cells with nonmodal DNA content values (Fig. 1). Con-
sequently, a genomically unstable cell line was defined by
a) unchanged high proliferative activity at confluence
and/or upon serum starvation, b) high percentage of cells
with nonmodal DNA content values (Fig. 1).
Flow cytometry
Single parameter DNA flow cytometry
For DNA histograms, cells were harvested and analysed as
described previously [33]. Briefly, cells were fixed in 4%
buffered formaldehyde for 18 hours at room temperature.
Formaldehyde was removed by 95% ethanol for 1 hour
followed by rehydration in distilled water for 1 hour. After
treatment with subtilisin Carlsberg solution [0.1% Sigma
protease XXIV, 0.1 M Tris and 0.07 M NaCl (pH 7,5)] and
staining with DAPI-Sulforhodamine solution [8 µM
DAPI, 50 µM Sulforhodamine 101, 0.1 M Tris and 0.07 M
NaCl (pH 7.5)], samples were analysed using a PAS II
flowcytometer (Partec, Münster, Germany) equipped with
a 100 W mercury arc lamp HBO 100. DAPI fluorescence
was measured above 435 nm. The multicycle program for
cell cycle analysis (Phoenix flow systems, San Diego, CA)
was used for histogram analysis; the number of nuclei/
histogram was 40,000. The S-phase was fitted to a broad-
ened trapezoidal model. For background correction the
sliced-nuclei model was applied.
Two parameter DNA-BrdU analysis
For BrdU (5'-Bromo-2'-deoxyuridine) labeling, cells were
precultured for 24 hours, pulse labeled for 10 minutes
with 20 µM BrdU, washed twice with culturing medium
and then recultured with new medium for 20 minutes,
followed by harvesting as before and fixation in 4% buff-
ered formaldehyde. Immunostaining was carried out
using a modified technique described by Sangfelt et al.
[42] with 2 mg/ml monoclonal anti-BrdU antibodies
(Boehringer Mannheim Scandinavia AB, Bromma, Swe-
den) for 1 hour at room temperature and FITC-conjugated
anti mouse IgG antibodies (F-0257, Sigma), diluted 1/100
in PBT (PBS, 2% BSA, 0,5% Tween 20) for 1 hour in the
dark at room temperature. DNA was stained with 10 µM
propidium iodide (PI) for 20 minutes. A Nikon fluores-
cence microscope equipped with a mercury arc lamp HBO
100 was used for control of the quality of immunostain-
ing. The samples were analysed in a FACScalibur flowcy-
tometer (Becton Dickinson, Sweden) for two-parameter
dot plot histogram analysis (BrdU incorporation vs. DNA
content).
Cell staining and indirect immunofluorescence
Indirect immunofluorescence was performed by the
method of Gong et al. [43]. As negative control, we usedBMC Cell Biology 2003, 4 http://www.biomedcentral.com/1471-2121/4/8
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FITC-conjugated mouse IgE monoclonal antibody
(13834X, Pharmingen). All four antibodies: cyclin E (HE
121, Santa Cruz Biotechnology), cyclin A (6E6, Novocas-
tra Laboratories UK), topoisomerase II α (Novocastra Lab-
oratories UK) and IgE were incubated for 1 hour at room
temperature, followed by incubation with the secondary
antibody (FITC-conjugated IgG anti mouse antibody) for
1 hour in the dark at room temperature diluted 1/100 in
PBT. DNA was stained with propidium iodide (10 µg/ml
in PBS+RNAse 1 mg/ml). The samples were kept in the
dark for 20 minutes before running them in the FACS. The
FACS was equipped with an argon laser; the FITC fluores-
cence was analysed at 515 nm and the PI at 488 nm.
20,000 events were stored for every sample. The Cell
Quest (Becton Dickinson) program was used for the two-
parameter dot plot histogram analysis.
Centrosome staining
Cells were seeded onto sterile glass slides in culture dishes
and cultivated for 3 days. After rinsing with PBS, cells were
fixed in methanol at -20°C for 10 min and in acetone at -
20°C for 6 min. After each incubation cells were exten-
sively rinsed with PBS. All procedures were done at room
temperature. Blocking solution (1% normal goat serum,
0.1% Tween 20/PBS) was applied to the cells for 30 min
at 37°C. Cells were incubated with anti γ-tubulin anti-
body (Sigma T6557), diluted 1:1000 in PBS, containing
2% normal goat serum, for 1 hour. Antibody-antigen
complexes were detected by FITC-conjugated anti mouse
IgG. Stained slides were mounted with Vectashield
mounting medium. With a Zeiss Axioskop fluorescence
microscope, the proportion of cells with more than two
centrosomes was counted in more than 500 cells of each
cell line.
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